Merit Medical Systems, Inc. - Common Stock (MMSI)
Healthcare › Surgical & Medical Instruments & Apparatus
Price History
Feb 9, 2026 — May 11, 2026Investment Snapshot
- Trading 67% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 6/9 — moderate financial health
- ROE of 8.1% — below-average profitability
- Revenue growing at 12% annually
Merit Medical Systems, Inc. - Common Stock (MMSI) is a Healthcare company operating in Surgical & Medical Instruments & Apparatus, listed on the NASDAQ , with a market capitalisation of $3.7 billion . Key value metrics: P/E ratio 27.8, P/B ratio 2.25, Piotroski F-Score 6 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Merit Medical Systems, Inc. - Common Stock — Fundamental Analysis Summary
Merit Medical Systems, Inc. - Common Stock (MMSI) is currently trading 67% above its Graham Number of $36.77, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 27.8x.
On financial health, MMSI shows a moderate Piotroski F-Score of 6/9, and modest return on equity of 8.1% (sector average: -20.6%), and manageable leverage with a debt-to-equity ratio of 0.45.
StockPik's composite Value Score for MMSI is 69/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
MMSI reports a solid gross margin of 48.4% (sector average: 40.1%) and a solid operating margin of 11.6%.
MMSI shows revenue growing at 12% year-over-year, with earnings growing at 7%.